AP
WST icon

Anchyra Partners’s West Pharmaceutical WST Stock Holding History

Anchyra Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Buy
2,257
+33
+1% +$10.1K 0.19% 99
2026
Q1 		$557K Buy
2,224
+5
+0.2% +$1.24K 0.17% 122
2025
Q4 		$611K Buy
+2,219
New +$607K 0.19% 106

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Anchyra Partners's WST Position: Q2 2026 in Review

Anchyra Partners increased its West Pharmaceutical (WST) stake by 1.5% in Q2 2026, buying an estimated $10.1K and bringing the position to 2,257 shares worth $810K. The position accounts for 0.19% of the portfolio, ranked #99.

Anchyra Partners first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 426 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Anchyra Partners held 2,257 shares of West Pharmaceutical worth $810K as of Q2 2026.
  • Anchyra Partners bought 33 West Pharmaceutical shares in Q2 2026, an estimated $10.1K.
  • West Pharmaceutical made up 0.19% of Anchyra Partners's portfolio in Q2 2026, its #99 holding.
  • Anchyra Partners first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 426 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.